Acurx Pharmaceuticals, Inc. (ACXP) Operating cash flow 2020–2025
Acurx Pharmaceuticals, Inc. (ACXP) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$6.8MFY2025 · since FY2020: -$3.4M → -$6.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$6.8M | +34.6% |
| FY2024 | -$10.4M | -5.9% |
| FY2023 | -$9.8M | -29.9% |
| FY2022 | -$7.5M | -50.4% |
| FY2021 | -$5.0M | -49.6% |
| FY2020 | -$3.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice